Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $17.1700 (-4.02%) ($17.1500 - $17.1700) on Mon. Feb. 22, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.06% (three month average) | RSI | 40 | Latest Price | $17.1700(-4.02%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1.5% a day on average for past five trading days. | Weekly Trend | ATRA declines -4.1% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Rotation from growth to value for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) IBB(45%) ARKK(44%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -1.53% in a week (0% probabilities). VIXM(-35%) VXX(-27%) IGOV(-15%) UNG(-11%) UUP(-9%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.53% (StdDev 3.06%) | Hourly BBV | -2.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $9.55(-44.38%) | Inflection Point | Yes | Resistance Level | $18.97 | 5 Day Moving Average | $17.94(-4.29%) | 10 Day Moving Average | $18.7(-8.18%) | 20 Day Moving Average | $18.97(-9.49%) | To recent high | -34.8% | To recent low | 0% | Market Cap | $1.276b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |